Deficiencies of GM-CSF and interferon γ link inflammation and cancer

被引:142
|
作者
Enzler, T
Gillessen, S
Manis, JP
Ferguson, D
Fleming, J
Alt, FW
Mihm, M
Dranoff, G
机构
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Childrens Hosp, Ctr Blood Res, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA
[6] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 2003年 / 197卷 / 09期
关键词
GM-CSF; IFN-gamma; cancer; inflammation; SLE;
D O I
10.1084/jem.20021258
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chronic inflammation contributes to carcinogenesis, but the underlying mechanisms are poorly understood. We report that aged granulocyte-macrophage colony stimulating factor (GM-CSF)-deficient mice develop a systemic lupus erythematosis (SLE)-like disorder associated with the impaired phagocytosis of apoptotic cells. Concurrent deficiency of interferon (IFN)-gamma attenuates the SLE, but promotes the formation of diverse hematologic and solid neoplasms within a background of persistent infection and inflammation. Whereas activated B cells show a resistance to fas-induced apoptosis, antimicrobial therapy prevents lymphomagenesis and solid tumor development. These findings demonstrate that the interplay of infectious agents with cytokine-mediated regulation of immune homeostasis is a critical determinant of cancer susceptibility.
引用
收藏
页码:1213 / 1219
页数:7
相关论文
共 50 条
  • [1] GM-CSF in inflammation
    Hamilton, John A.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2020, 217 (01):
  • [2] GM-CSF in inflammation and autoimmunity
    Hamilton, JA
    TRENDS IN IMMUNOLOGY, 2002, 23 (08) : 403 - 408
  • [3] THE ROLE OF GM-CSF IN CUTANEOUS INFLAMMATION
    OBERYSZYN, AS
    OBERYSZYN, TM
    SABOURIN, CLK
    BIJUR, GN
    BOROS, LG
    ROBERTSON, FM
    JOURNAL OF LEUKOCYTE BIOLOGY, 1993, : 84 - 84
  • [4] Incidence of GM-CSF antibodies in cancer patients receiving GM-CSF for immunostimulation
    Ullenhag, G
    Bird, C
    Ragnhammar, P
    Frödin, JE
    Strigård, K
    Österborg, A
    Thorpe, R
    Mellstedt, H
    Wadhwa, M
    CLINICAL IMMUNOLOGY, 2001, 99 (01) : 65 - 74
  • [5] GM-CSF: A Promising Target in Inflammation and Autoimmunity
    Lee, Kevin M. C.
    Achuthan, Adrian A.
    Hamilton, John A.
    IMMUNOTARGETS AND THERAPY, 2020, 9 : 225 - 240
  • [6] Effector functions of GM-CSF in CNS inflammation
    Lysann, Hesske
    Christine, Vincenzetti
    Britta, Engelhardt
    Stefan, Tschanz
    Marco, Prinz
    Mathias, Heikenwalder
    Walter, Reith
    Adriano, Fontana
    Tobias, Suter
    JOURNAL OF NEUROIMMUNOLOGY, 2010, 228 (1-2) : 105 - 105
  • [7] Pivotal Roles of GM-CSF in Autoimmunity and Inflammation
    Shiomi, Aoi
    Usui, Takashi
    MEDIATORS OF INFLAMMATION, 2015, 2015
  • [8] The role of GM-CSF in adipose tissue inflammation
    Kim, Dong-Hoon
    Sandoval, Darleen
    Reed, Jacquelyn A.
    Matter, Emily K.
    Tolod, Emeline G.
    Woods, Stephen C.
    Seeley, Randy J.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2008, 295 (05): : E1038 - E1046
  • [9] Expression of GM-CSF and action of GM-CSF in cholesteatoma
    Wuhan Gangtie Xueyuan Xuebao, 4 (409-411):
  • [10] The role of GM-CSF in enhancing immunotherapy of cancer
    Thorne, Steve H.
    IMMUNOTHERAPY, 2013, 5 (08) : 817 - 819